InFlammaNova Rx Email Formats

About InFlammaNova Rx

At InFlammaNova Rx, we are at the forefront of developing innovative therapies for neuroinflammatory and neurodegenerative diseases. Our mission is to harness the potential of novel compounds to offer new hope for conditions that currently lack effective treatments. Our central focus is on the development of stimulator of interferon genes (STING) protein inhibitors, targeting Parkinson’s disease (PD) and related neuroinflammatory disorders. With such neuro-related diseases affecting over 50 million people globally, we are tapping into a projected $50B marketplace. Led by a group of seasoned researchers, our team's diverse expertise spans medicinal chemistry, immunology, pharmacology, and clinical research. We are committed to innovation and excellence, driven by a passion to make a tangible difference in the lives of those affected by neuroinflammatory and neurodegenerative diseases. Collaboration is at our core, and we take pride in working alongside leading scientists, clinicians, and patient advocacy groups to advance our research and development efforts. Join us on our journey to redefine the treatment landscape for neuroinflammatory and neurodegenerative diseases.

View contact profiles from InFlammaNova Rx